$IMUX
Immunic, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, United States
IMUX chart
What traders are saying about $IMUX
Latest postsImmunic, Inc. news
- Cantor Fitzgerald starts coverage of Immunic stock with Overweight rating
ad-hoc-news.de ·
- Bioprocessing observability: why real-time monitoring matters
Pharma Voice ·
- MS has plenty of drugs. This Ocrevus veteran sees what’s missing.
Pharma Voice ·
- Early treatment may ease long-term disability in progressive MS
Multiple Sclerosis News Today ·
- H.C. Wainwright sets USD 22.00 target for Immunic stock
ad-hoc-news.de ·
- Immunic, Inc. Estimates – DUS:10V
TradingView ·
- IMUX Initiates Coverage On by Cantor Fitzgerald -- Rating Set to Overweight
GuruFocus ·
- Immunic stock: Wall Street Zen downgrades Immunic stock to Sell
ad-hoc-news.de ·
- New Strong Buy Stocks for October 22nd
Yahoo Finance ·
- CALLIPER Extension Data Show Sustained Disability Outcomes With Vidofludimus Calcium in Progressive MS
NeurologyLive ·
- Immunic presents data on vidofludimus calcium at MS conference By Investing.com
Investing.com South Africa ·
- Immunic presents data on vidofludimus calcium at MS conference
Investing.com ·
Immunic, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$97.2M | -$100.5M | -$93.6M | -$120.4M |
| Diluted EPS | $-0.62 | $-1.00 | $-2.11 | $-3.78 |
| Total assets (year end) | $24.1M | $40.9M | $54.3M | $127.8M |
| Cash and equivalents (year end) | $15.5M | $35.7M | $46.7M | $106.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 10-Q10-Q
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- DEF 14AProxy statement
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
About Immunic, Inc.
- Ticker
- IMUX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1280776
- Former names
- VITAL THERAPIES INC
Frequently asked questions
What exchange is Immunic, Inc. listed on?
Immunic, Inc. trades on the Nasdaq under the ticker symbol IMUX.
What industry is Immunic, Inc. in?
Immunic, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Immunic, Inc. headquartered?
Immunic, Inc.'s business address on file with the SEC is in New York, United States.
When does Immunic, Inc.'s fiscal year end?
Immunic, Inc.'s fiscal year ends on December 31.